Telepharmacy During COVID-19: A Scoping Review

Overview

Journal Pharmacy (Basel)

Date 2021 Nov 29

PMID 34842823

Citations 36

Authors

Elizabeth J Unni

Kanchita Patel

Isaac Rex Beazer

Man Hung

Affiliations

Soon will be listed here.

Abstract

The objective of this scoping review is to summarize the implementation of telepharmacy during the surge of COVID-19. This review will focus on answering four questions: During the COVID-19 pandemic, (1) what were the various telepharmacy initiatives implemented? (2) what were the challenges faced when implementing telehealth initiatives? (3) what were the strategies used by pharmacies to overcome the challenges, and (4) what were some of the innovative methods used by pharmacies to implement telepharmacy? A literature search was conducted to include publications post-March 2020 about telepharmacy implementation via PubMed Central database and Google searches. All articles were examined for inclusion or exclusion based on pre-determined criteria. A total of 33 articles were reviewed. The most commonly observed telepharmacy initiatives were virtual consultations, home delivery of medicines and patient education. Limited access to technology and lack of digital access and literacy were major barriers in the implementation of telepharmacy. New protocols were developed by healthcare systems and regulations were relaxed by countries to accommodate telepharmacy. Pharmacies that successfully implemented telepharmacy overcame these challenges through patient and pharmacist education. The review also revealed the steps that can be taken by pharmacy organizations, payers and entrepreneurs in leveraging the convenience of telepharmacy.

Citing Articles

Bibliometric and visual analysis of medication therapy management from 2003 to 2023.

Guo Z, Fu L, Chu Z, Gao S, Lu L, Jiao W Medicine (Baltimore). 2024; 103(51):e40953.

PMID: 39705411 PMC: 11666177. DOI: 10.1097/MD.0000000000040953.

An assessment of the knowledge, perception, and willingness to use telepharmacy services among the general public in Riyadh.

Imam M, AlAnazi K, AlMakwini A, Alahmadi Z, Ali M, AlQahtani K Medicine (Baltimore). 2024; 103(50):e40853.

PMID: 39686485 PMC: 11651506. DOI: 10.1097/MD.0000000000040853.

A Qualitative Study of Pharmacists' Perceptions of the Advantages and Disadvantages of Telepharmacy.

Shoji M, Onda M Pharmacy (Basel). 2024; 12(6).

PMID: 39585095 PMC: 11587400. DOI: 10.3390/pharmacy12060169.

Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model.

Zarate-Tamames B, Garin N, Calvin-Lamas M, Jornet S, Martinez-Simon J, Garcia-Gil S Front Pharmacol. 2024; 15:1461473.

PMID: 39512818 PMC: 11540901. DOI: 10.3389/fphar.2024.1461473.

Assessment of knowledge, perception, and readiness for telepharmacy-assisted pharmaceutical services among young pharmacists in rural Indonesia.

Ghozali M Explor Res Clin Soc Pharm. 2024; 16:100513.

PMID: 39430718 PMC: 11489386. DOI: 10.1016/j.rcsop.2024.100513.

References

Margusino-Framinan L, Illarro-Uranga A, Lorenzo-Lorenzo K, Monte-Boquet E, Marquez-Saavedra E, Fernandez-Bargiela N . Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy. Farm Hosp. 2020; 44(7):61-65. DOI: 10.7399/fh.11498. View

Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C . The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg. 2020; 78:185-193. PMC: 7162753. DOI: 10.1016/j.ijsu.2020.04.018. View

Elbeddini A, Yeats A . Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine. J Pharm Policy Pract. 2020; 13:23. PMC: 7251049. DOI: 10.1186/s40545-020-00229-z. View

Miller I, Becker A, Grenfell B, Metcalf C . Disease and healthcare burden of COVID-19 in the United States. Nat Med. 2020; 26(8):1212-1217. DOI: 10.1038/s41591-020-0952-y. View

Hua X, Gu M, Zeng F, Hu H, Zhou T, Zhang Y . Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. J Am Pharm Assoc (2003). 2020; 60(3):431-438.e1. PMC: 7146685. DOI: 10.1016/j.japh.2020.04.006. View

Li H, Zheng S, Liu F, Liu W, Zhao R . Fighting against COVID-19: Innovative strategies for clinical pharmacists. Res Social Adm Pharm. 2020; 17(1):1813-1818. PMC: 7194937. DOI: 10.1016/j.sapharm.2020.04.003. View

Segal E, Alwan L, Pitney C, Taketa C, Indorf A, Held L . Establishing clinical pharmacist telehealth services during the COVID-19 pandemic. Am J Health Syst Pharm. 2021; 77(17):1403-1408. PMC: 7314203. DOI: 10.1093/ajhp/zxaa184. View

Muflih S, Al-Azzam S, Abuhammad S, Jaradat S, Karasneh R, Shawaqfeh M . Pharmacists' experience, competence and perception of telepharmacy technology in response to COVID-19. Int J Clin Pract. 2021; 75(7):e14209. PMC: 8250242. DOI: 10.1111/ijcp.14209. View

Birkmeyer J, Barnato A, Birkmeyer N, Bessler R, Skinner J . The Impact Of The COVID-19 Pandemic On Hospital Admissions In The United States. Health Aff (Millwood). 2020; 39(11):2010-2017. PMC: 7769002. DOI: 10.1377/hlthaff.2020.00980. View

10.

Mallhi T, Liaqat A, Abid A, Khan Y, Alotaibi N, Alzarea A . Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward. Front Public Health. 2020; 8:561924. PMC: 7753011. DOI: 10.3389/fpubh.2020.561924. View

11.

Yemm K, Arnall J, Cowgill N . Necessity of pharmacist-driven nonprescription telehealth consult services in the era of COVID-19. Am J Health Syst Pharm. 2020; 77(15):1188. PMC: 7239252. DOI: 10.1093/ajhp/zxaa162. View

12.

Mohamed Ibrahim O, Ibrahim R, H Abdel-Qader D, Al Meslamani A, Al Mazrouei N . Evaluation of Telepharmacy Services in Light of COVID-19. Telemed J E Health. 2020; 27(6):649-656. DOI: 10.1089/tmj.2020.0283. View

13.

Hossain M, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L . Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020; 9:636. PMC: 7549174. DOI: 10.12688/f1000research.24457.1. View

14.

Hanjani L, Bell J, Freeman C . Undertaking medication review by telehealth. Aust J Gen Pract. 2020; 49(12):826-831. DOI: 10.31128/AJGP-06-20-5461. View

15.

Hedima E, Okoro R . Telepharmacy: An opportunity for community pharmacists during the COVID-19 pandemic in Sub Saharan Africa. Health Policy Technol. 2020; 10(1):23-24. PMC: 7609244. DOI: 10.1016/j.hlpt.2020.10.013. View

16.

Elson E, Oermann C, Duehlmeyer S, Bledsoe S . Use of telemedicine to provide clinical pharmacy services during the SARS-CoV-2 pandemic. Am J Health Syst Pharm. 2020; 77(13):1005-1006. PMC: 7239265. DOI: 10.1093/ajhp/zxaa112. View

17.

Shuman A, Fox E, Unguru Y . COVID-19 and Drug Shortages: A Call to Action. J Manag Care Spec Pharm. 2020; 26(8):945-947. PMC: 10391236. DOI: 10.18553/jmcp.2020.26.8.945. View

18.

Killeen R, Grindrod K, Ong S . Innovations in practice: Telepharmacy's time has arrived. Can Pharm J (Ott). 2020; 153(5):252-255. PMC: 7560556. DOI: 10.1177/1715163520945732. View

19.

Koster E, Philbert D, Bouvy M . Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Res Social Adm Pharm. 2020; 17(1):2002-2004. PMC: 7330552. DOI: 10.1016/j.sapharm.2020.07.001. View

20.

Bejarano A, Villar Santos P, Robustillo-Cortes M, Sanchez Gomez E, Santos Rubio M . Implementation of a novel home delivery service during pandemic. Eur J Hosp Pharm. 2020; 28(Suppl 2):e120-e123. PMC: 8640397. DOI: 10.1136/ejhpharm-2020-002500. View